Medtronic Website Promotes Activa For Off-Label Uses - FDA Warning Letter
This article was originally published in The Gray Sheet
Executive Summary
Medtronic and FDA are continuing discussions about appropriate disclaimers for promotional material on the firm's website related to uses of its Activa tremor control system that are not yet approved in the U.S., following receipt of a March 23 warning letter.